lOM oA R
728 229
b b cP S D| 13
lOM oA R b b
cP S D| 137 28 229
Lilleys Pharmacology for Canadian H
b b b b
are Practice 4th Edition Sealock Tes
b b b b b
hapter 1- b
58 Questions and Correct Answers w
b b b b b b
onales Rated A+ b b
, lOM oA R
728 229
b b
cP S D| 13
Chapter 01: Nursing Practice in Canada and Drug Therapy
b b b b b b b b
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
b b b b b b b b b
MULTIPLEbCHOICE
1. Whichbisbabjudgementbaboutbabparticularbpatient’sbpotentialbneedborbproblem?
a. Abgoal
b. Anbassessment
c. Subjectivebdata
d. Abnursingbdiagnosis
ANS:b D
Nursingbdiagnosisbisbthebphasebofbthebnursingbprocessbduringbwhichbabclinicalbjudgementbisbmadebaboutbho
athbconditionsbandblifebprocessesborbvulnerabilitybforbthatbresponse.
DIF: CognitivebLevel:bKnowledge
2. Thebpatientbisbtobreceiveboralbfurosemideb(Lasix)beverybday;bhowever,bbecausebthebpatientbisbunablebtobsw
edicationborally,basbordered.bThebnursebneedsbtobcontactbthebphysician.bWhatbtypebofbproblembisbthis?
a. Ab“rightbtime”bproblem
b. Ab“rightbdose”bproblem
c. Ab“rightbroute”bproblem
d. Ab“rightbmedication”bproblem
ANS:b C
Thisbisbab“rightbroute”bproblem:bthebnursebcannotbassumebthebroutebandbmustbclarifybthebroutebwithbthebpre
me”bproblembbecausebtheborderedbfrequencybhasbnotbchanged.bThisbisbnotbab“rightbdose”bproblembbecause
nabilitybtobswallow.bThisbisbnotbab“rightbmedication”bproblembbecausebthebmedicationborderedbwillbnotbch
DIF: CognitivebLevel:bApplication
3. Thebnursebhasbbeenbmonitoringbthebpatient’sbprogressbonbhisbnewbdrugbregimenbsincebthebfirstbdosebandbha
possiblebadversebeffects.bWhatbnursingbprocessbphasebisbthebnursebpractising?
b
a. Planning
b. Evaluation
c. Implementation
d. Nursingbdiagnosis
ANS:b B
Monitoringbthebpatient’sbprogressbisbpartbofbthebevaluationbphase.bPlanning,bimplementation,bandbnursingb
dbbybthisbexample.
DIF: CognitivebLevel:bApplication
4. Thebnursebisbcaringbforbabpatientbwhobhasbbeenbnewlybdiagnosedbwithbtypeb1bdiabetesbmellitus.bWhichbstat
utcomebcriterionbforbthisbpatient?
a. Thebpatientbwillbfollowbinstructions.
b. Thebpatientbwillbnotbexperiencebcomplications.
c. Thebpatientbadheresbtobthebnewbinsulinbtreatmentbregimen.
d. Thebpatientbdemonstratesbsafebinsulinbself-administrationbtechnique.
ANS:b D
Havingbthebpatientbdemonstratebsafebinsulinbself-
administrationbtechniquebisbabspecificbandbmeasurableboutcomebcriterion.bFollowingbinstructionsbandbavoi
pecificbcriteria.bAdherencebtobthebnewbinsulinbtreatmentbregimenbisbnotbobjectivebandbwouldbbebdifficultbto
DIF: CognitivebLevel:bApplication
5. Whichbactivitybbestbreflectsbthebimplementationbphasebofbthebnursingbprocessbforbthebpatientbwhobisbnewly
, lOM oA R
728 229
b b
cP S D| 13
6. Thebnursebisbworkingbduringbabverybbusybnightbshift,bandbthebhealthbcarebproviderbhasbjustbgivenbthebnurse
ebtelephone,bbutbthebnursebdoesbnotbrecallbthebroute.bWhatbisbthebbestbwaybforbthebnursebtobavoidbmedicatio
a. Recopybtheborderbneatlybonbtheborderbsheet,bwithbthebmostbcommonbroutebindicated
b. Consultbwithbthebpharmacistbforbclarificationbaboutbthebmostbcommonbroute
c. Callbthebhealthbcarebproviderbtobclarifybthebroutebofbadministration
d. Withholdbthebdrugbuntilbthebhealthbcarebproviderbvisitsbthebpatient
ANS:b C
Ifbabmedicationborderbdoesbnotbincludebthebroute,bthebnursebmustbaskbthebhealthbcarebproviderbtobclarifybit.b
ministration.
DIF: CognitivebLevel:bApplicationb|bCognitivebLevel:bAnalysis
7. WhichbconstitutesbthebtraditionalbFivebRightsbofbmedicationbadministration?
a. Rightbdrug,brightbroute,brightbdose,brightbtime,bandbrightbpatient
b. Rightbdrug,bthebrightbeffect,bthebrightbroute,bthebrightbtime,bandbthebrightbpatient
c. Rightbpatient,brightbstrength,brightbdiagnosis,brightbdrug,bandbrightbroute
d. Rightbpatient,brightbdiagnosis,brightbdrug,brightbroute,bandbrightbtime
ANS:b A
ThebtraditionalbFivebRightsbofbmedicationbadministrationbwerebconsideredbtobbebRightbdrug,bRightbroute,bR
bpatient.bRightbeffect, brightbstrength, bandbright bdiagnosisbarebnotbpartbofbthebtraditionalbFivebRights.
DIF: CognitivebLevel:bComprehension
8. Whatbcorrectlybdescribesbthebnursingbprocess?
a. Diagnosing,bplanning,bassessing,bimplementing,bandbfinallybevaluating
b. Assessing,bthenbdiagnosing,bimplementing,bandbendingbwithbevaluating
c. Ablinearbdirectionbthatbbeginsbwithbassessingbandbcontinuesbthroughbdiagnosing,b
planning,bandbfinallybimplementing
d. Anbongoingbprocessbthatbbeginsbwithbassessingbandbcontinuesbwithbdiagnosing,b
planning,bimplementing,bandbevaluating
ANS:b D
Thebnursingbprocessbisbanbongoing,bflexible,badaptable,bandbadjustablebfive-
stepbprocessbthatbbeginsbwithbassessingbandbcontinuesbthroughbdiagnosing,bplanning,bimplementing,bandbf
nbleadbbackbtobanybofbthebotherbphases.
DIF: CognitivebLevel:bApplication
9. Whenbthebnursebisbconsideringbthebtimingbofbabdrugbdose,bwhichbisbmostbimportantbtobassess?
a. Thebpatient’sbidentification
b. Thebpatient’sbweight
c. Thebpatient’sblastbmeal
d. Anybdrugborbfoodballergies
ANS:b C
Thebpharmacokineticbandbpharmacodynamicbpropertiesbofbthebdrugbneedbtobbebassessedbwithbregardbtoban
foodbinteractionsborbcompatibilitybissues.bThebpatient’sbidentification,bweight,bandbdrugborbfoodballergiesba
timing.
DIF: CognitivebLevel:bApplication
10. Thebnursebisbwritingbnursingbdiagnosesbforbabplanbofbcare.bWhichbreflectsbthebcorrectbformatbforbherbnursin
a. Anxiety
b. Anxietybrelatedbtobnewbdrugbtherapy
c. Anxietybrelatedbtobanxiousbfeelingsbaboutbdrugbtherapy,basbevidencedbbybs
tatementsbsuchbasb“I’mbupsetbaboutbhavingbtobgivebmyselfbshots”
d. Anxietybrelatedbtobnewbdrugbtherapy,basbevidencedbbybstatementsbsuchbasb“I’mbu
psetbaboutbhavingbtobgivebmyselfbshots”
, lOM oA R
728 229
b b
cP S D| 13
Chapter 02: Pharmacological Principles
b b b
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
b b b b b b b b b
MULTIPLEbCHOICE
1. Abpatientbisbreceivingbtwobdifferentbdrugs,bwhich,batbtheirbcurrentbdosebformsbandbdosages,barebbothbabsor
enticalbamounts.bWhichbtermbbestbdenotesbthatbthebdrugsbhavebthebsamebabsorptionbrates?
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS:b D
Twobdrugsbabsorbedbintobthebcirculationbatbthebsamebamountb(inbspecificbdosagebforms)bhavebthebsamebbio
oequivalent.b“Equivalent”bisbincorrectbbecausebthebtermb“bioavailability”bisbusedbtobexpressbthebextentbofb
c”bisbincorrectbbecausebthisbtermbrefersbtobtwobdrugsbgivenbtogetherbwhosebresultingbeffectbisbgreaterbthanb
bdrugbgivenbalone.b“Compatible”bisbincorrect bbecausebthisbtermbisbabgeneral btermbusedbtobindicatebthatbtwo
micalbreactionbwhenbmixedb(orbgiven,binbthebcasebofbdrugs)btogether.
DIF: CognitivebLevel:bComprehension
2. Abpatientbisbreceivingbmedicationbviabintravenousbinjection.bWhichbinformationbshouldbthebnursebprovide
a. Thebmedicationbwillbcausebfewerbadversebeffectsbwhenbgivenbintravenously.
b. Thebmedicationbwillbbebabsorbedbslowlybintobthebtissuesboverbtime.
c. Thebmedication’sbactionbwillbbeginbfasterbwhenbgivenbintravenously.
d. Mostbofbthebdrugbisbinactivatedbbybthebliverbbeforebitbreachesbthebtargetbarea.
ANS:b C
Intravenousbinjectionsbarebthebfastestbroutebofbabsorption.bThebintravenousbroutebdoesbnotbaffectbthebnumb
travenousbroutebisbnotbabslowbroutebofbabsorption,bandbthebintravenousbroutebdoesbnotbcausebinactivationbo
rebitbreachesbthebtargetbarea.
DIF: CognitivebLevel:bComprehension
3. Whichbisbtruebregardingbparenteralbdrugs?
a. Theybbypassbthebfirst-passbeffect.
b. Theybdecreasebbloodbflowbtobthebstomach.
c. Theybarebalteredbbybthebpresencebofbfoodbinbthebstomach.
d. Theybexertbtheirbeffectsbwhilebcirculatingbinbthebbloodstream.
ANS:b A
Drugsbgivenbbybthebparenteralbroutebbypassbthebfirst-
passbeffect,bbutbtheybstillbmustbbebabsorbedbintobcellsbandbtissuesb beforebtheybcanbexertbtheirbeffects.bEntera
notbparenteralbdrugs,bdecreasebbloodbflowbtobthebstomachbandbarebalteredbbybthebpresencebofbfoodbinbthebst
tbbebabsorbedbintobcellsbandbtissuesbfrombthebcirculationbbeforebtheybcanbexertbtheirbeffects;btheybdobnotbex
tingbinbthebbloodstream.
DIF: CognitivebLevel:bAnalysis
4. Abdrug’sbhalf-lifebisbbestbdefinedbas
a. Thebtimebitbtakesbforbthebdrugbtobelicitbhalfbitsbtherapeuticbresponse.
b. Thebtimebitbtakesbone-
halfbofbtheboriginalbamountbofbabdrugbtobreachbthebtargetbcells.
c. Thebtimebitbtakesbone-
halfbofbtheboriginalbamountbofbabdrugbtobbebremovedbfrombthebbody.
d. Thebtimebitbtakesbone-
halfbofbtheboriginalbamountbofbabdrugbtobbebabsorbedbintobthebcirculation.
ANS:b C
728 229
b b cP S D| 13
lOM oA R b b
cP S D| 137 28 229
Lilleys Pharmacology for Canadian H
b b b b
are Practice 4th Edition Sealock Tes
b b b b b
hapter 1- b
58 Questions and Correct Answers w
b b b b b b
onales Rated A+ b b
, lOM oA R
728 229
b b
cP S D| 13
Chapter 01: Nursing Practice in Canada and Drug Therapy
b b b b b b b b
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
b b b b b b b b b
MULTIPLEbCHOICE
1. Whichbisbabjudgementbaboutbabparticularbpatient’sbpotentialbneedborbproblem?
a. Abgoal
b. Anbassessment
c. Subjectivebdata
d. Abnursingbdiagnosis
ANS:b D
Nursingbdiagnosisbisbthebphasebofbthebnursingbprocessbduringbwhichbabclinicalbjudgementbisbmadebaboutbho
athbconditionsbandblifebprocessesborbvulnerabilitybforbthatbresponse.
DIF: CognitivebLevel:bKnowledge
2. Thebpatientbisbtobreceiveboralbfurosemideb(Lasix)beverybday;bhowever,bbecausebthebpatientbisbunablebtobsw
edicationborally,basbordered.bThebnursebneedsbtobcontactbthebphysician.bWhatbtypebofbproblembisbthis?
a. Ab“rightbtime”bproblem
b. Ab“rightbdose”bproblem
c. Ab“rightbroute”bproblem
d. Ab“rightbmedication”bproblem
ANS:b C
Thisbisbab“rightbroute”bproblem:bthebnursebcannotbassumebthebroutebandbmustbclarifybthebroutebwithbthebpre
me”bproblembbecausebtheborderedbfrequencybhasbnotbchanged.bThisbisbnotbab“rightbdose”bproblembbecause
nabilitybtobswallow.bThisbisbnotbab“rightbmedication”bproblembbecausebthebmedicationborderedbwillbnotbch
DIF: CognitivebLevel:bApplication
3. Thebnursebhasbbeenbmonitoringbthebpatient’sbprogressbonbhisbnewbdrugbregimenbsincebthebfirstbdosebandbha
possiblebadversebeffects.bWhatbnursingbprocessbphasebisbthebnursebpractising?
b
a. Planning
b. Evaluation
c. Implementation
d. Nursingbdiagnosis
ANS:b B
Monitoringbthebpatient’sbprogressbisbpartbofbthebevaluationbphase.bPlanning,bimplementation,bandbnursingb
dbbybthisbexample.
DIF: CognitivebLevel:bApplication
4. Thebnursebisbcaringbforbabpatientbwhobhasbbeenbnewlybdiagnosedbwithbtypeb1bdiabetesbmellitus.bWhichbstat
utcomebcriterionbforbthisbpatient?
a. Thebpatientbwillbfollowbinstructions.
b. Thebpatientbwillbnotbexperiencebcomplications.
c. Thebpatientbadheresbtobthebnewbinsulinbtreatmentbregimen.
d. Thebpatientbdemonstratesbsafebinsulinbself-administrationbtechnique.
ANS:b D
Havingbthebpatientbdemonstratebsafebinsulinbself-
administrationbtechniquebisbabspecificbandbmeasurableboutcomebcriterion.bFollowingbinstructionsbandbavoi
pecificbcriteria.bAdherencebtobthebnewbinsulinbtreatmentbregimenbisbnotbobjectivebandbwouldbbebdifficultbto
DIF: CognitivebLevel:bApplication
5. Whichbactivitybbestbreflectsbthebimplementationbphasebofbthebnursingbprocessbforbthebpatientbwhobisbnewly
, lOM oA R
728 229
b b
cP S D| 13
6. Thebnursebisbworkingbduringbabverybbusybnightbshift,bandbthebhealthbcarebproviderbhasbjustbgivenbthebnurse
ebtelephone,bbutbthebnursebdoesbnotbrecallbthebroute.bWhatbisbthebbestbwaybforbthebnursebtobavoidbmedicatio
a. Recopybtheborderbneatlybonbtheborderbsheet,bwithbthebmostbcommonbroutebindicated
b. Consultbwithbthebpharmacistbforbclarificationbaboutbthebmostbcommonbroute
c. Callbthebhealthbcarebproviderbtobclarifybthebroutebofbadministration
d. Withholdbthebdrugbuntilbthebhealthbcarebproviderbvisitsbthebpatient
ANS:b C
Ifbabmedicationborderbdoesbnotbincludebthebroute,bthebnursebmustbaskbthebhealthbcarebproviderbtobclarifybit.b
ministration.
DIF: CognitivebLevel:bApplicationb|bCognitivebLevel:bAnalysis
7. WhichbconstitutesbthebtraditionalbFivebRightsbofbmedicationbadministration?
a. Rightbdrug,brightbroute,brightbdose,brightbtime,bandbrightbpatient
b. Rightbdrug,bthebrightbeffect,bthebrightbroute,bthebrightbtime,bandbthebrightbpatient
c. Rightbpatient,brightbstrength,brightbdiagnosis,brightbdrug,bandbrightbroute
d. Rightbpatient,brightbdiagnosis,brightbdrug,brightbroute,bandbrightbtime
ANS:b A
ThebtraditionalbFivebRightsbofbmedicationbadministrationbwerebconsideredbtobbebRightbdrug,bRightbroute,bR
bpatient.bRightbeffect, brightbstrength, bandbright bdiagnosisbarebnotbpartbofbthebtraditionalbFivebRights.
DIF: CognitivebLevel:bComprehension
8. Whatbcorrectlybdescribesbthebnursingbprocess?
a. Diagnosing,bplanning,bassessing,bimplementing,bandbfinallybevaluating
b. Assessing,bthenbdiagnosing,bimplementing,bandbendingbwithbevaluating
c. Ablinearbdirectionbthatbbeginsbwithbassessingbandbcontinuesbthroughbdiagnosing,b
planning,bandbfinallybimplementing
d. Anbongoingbprocessbthatbbeginsbwithbassessingbandbcontinuesbwithbdiagnosing,b
planning,bimplementing,bandbevaluating
ANS:b D
Thebnursingbprocessbisbanbongoing,bflexible,badaptable,bandbadjustablebfive-
stepbprocessbthatbbeginsbwithbassessingbandbcontinuesbthroughbdiagnosing,bplanning,bimplementing,bandbf
nbleadbbackbtobanybofbthebotherbphases.
DIF: CognitivebLevel:bApplication
9. Whenbthebnursebisbconsideringbthebtimingbofbabdrugbdose,bwhichbisbmostbimportantbtobassess?
a. Thebpatient’sbidentification
b. Thebpatient’sbweight
c. Thebpatient’sblastbmeal
d. Anybdrugborbfoodballergies
ANS:b C
Thebpharmacokineticbandbpharmacodynamicbpropertiesbofbthebdrugbneedbtobbebassessedbwithbregardbtoban
foodbinteractionsborbcompatibilitybissues.bThebpatient’sbidentification,bweight,bandbdrugborbfoodballergiesba
timing.
DIF: CognitivebLevel:bApplication
10. Thebnursebisbwritingbnursingbdiagnosesbforbabplanbofbcare.bWhichbreflectsbthebcorrectbformatbforbherbnursin
a. Anxiety
b. Anxietybrelatedbtobnewbdrugbtherapy
c. Anxietybrelatedbtobanxiousbfeelingsbaboutbdrugbtherapy,basbevidencedbbybs
tatementsbsuchbasb“I’mbupsetbaboutbhavingbtobgivebmyselfbshots”
d. Anxietybrelatedbtobnewbdrugbtherapy,basbevidencedbbybstatementsbsuchbasb“I’mbu
psetbaboutbhavingbtobgivebmyselfbshots”
, lOM oA R
728 229
b b
cP S D| 13
Chapter 02: Pharmacological Principles
b b b
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
b b b b b b b b b
MULTIPLEbCHOICE
1. Abpatientbisbreceivingbtwobdifferentbdrugs,bwhich,batbtheirbcurrentbdosebformsbandbdosages,barebbothbabsor
enticalbamounts.bWhichbtermbbestbdenotesbthatbthebdrugsbhavebthebsamebabsorptionbrates?
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS:b D
Twobdrugsbabsorbedbintobthebcirculationbatbthebsamebamountb(inbspecificbdosagebforms)bhavebthebsamebbio
oequivalent.b“Equivalent”bisbincorrectbbecausebthebtermb“bioavailability”bisbusedbtobexpressbthebextentbofb
c”bisbincorrectbbecausebthisbtermbrefersbtobtwobdrugsbgivenbtogetherbwhosebresultingbeffectbisbgreaterbthanb
bdrugbgivenbalone.b“Compatible”bisbincorrect bbecausebthisbtermbisbabgeneral btermbusedbtobindicatebthatbtwo
micalbreactionbwhenbmixedb(orbgiven,binbthebcasebofbdrugs)btogether.
DIF: CognitivebLevel:bComprehension
2. Abpatientbisbreceivingbmedicationbviabintravenousbinjection.bWhichbinformationbshouldbthebnursebprovide
a. Thebmedicationbwillbcausebfewerbadversebeffectsbwhenbgivenbintravenously.
b. Thebmedicationbwillbbebabsorbedbslowlybintobthebtissuesboverbtime.
c. Thebmedication’sbactionbwillbbeginbfasterbwhenbgivenbintravenously.
d. Mostbofbthebdrugbisbinactivatedbbybthebliverbbeforebitbreachesbthebtargetbarea.
ANS:b C
Intravenousbinjectionsbarebthebfastestbroutebofbabsorption.bThebintravenousbroutebdoesbnotbaffectbthebnumb
travenousbroutebisbnotbabslowbroutebofbabsorption,bandbthebintravenousbroutebdoesbnotbcausebinactivationbo
rebitbreachesbthebtargetbarea.
DIF: CognitivebLevel:bComprehension
3. Whichbisbtruebregardingbparenteralbdrugs?
a. Theybbypassbthebfirst-passbeffect.
b. Theybdecreasebbloodbflowbtobthebstomach.
c. Theybarebalteredbbybthebpresencebofbfoodbinbthebstomach.
d. Theybexertbtheirbeffectsbwhilebcirculatingbinbthebbloodstream.
ANS:b A
Drugsbgivenbbybthebparenteralbroutebbypassbthebfirst-
passbeffect,bbutbtheybstillbmustbbebabsorbedbintobcellsbandbtissuesb beforebtheybcanbexertbtheirbeffects.bEntera
notbparenteralbdrugs,bdecreasebbloodbflowbtobthebstomachbandbarebalteredbbybthebpresencebofbfoodbinbthebst
tbbebabsorbedbintobcellsbandbtissuesbfrombthebcirculationbbeforebtheybcanbexertbtheirbeffects;btheybdobnotbex
tingbinbthebbloodstream.
DIF: CognitivebLevel:bAnalysis
4. Abdrug’sbhalf-lifebisbbestbdefinedbas
a. Thebtimebitbtakesbforbthebdrugbtobelicitbhalfbitsbtherapeuticbresponse.
b. Thebtimebitbtakesbone-
halfbofbtheboriginalbamountbofbabdrugbtobreachbthebtargetbcells.
c. Thebtimebitbtakesbone-
halfbofbtheboriginalbamountbofbabdrugbtobbebremovedbfrombthebbody.
d. Thebtimebitbtakesbone-
halfbofbtheboriginalbamountbofbabdrugbtobbebabsorbedbintobthebcirculation.
ANS:b C
